Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension

American Journal of Hematology

Volumn 83, Issue 11, 2008, Pages 850-854

  Van Beers, Eduard J ^a,b   Nur, Erfan ^a,b   Schaefer Prokop, Cornelia M ^a   Mac Gillavry, Melvin R ^b   Van Esser, Joost W J ^c   Brandjes, Dees P M ^b   Kappers Klunne, Maria C ^c   Duits, Ashley J ^d   Muskiet, Frits A J ^e   Schnog, John John B ^b,c,d   Biemond, Bart J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Red Cross Blood Bank Foundation   (Netherlands Antilles)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AMBULATORY CARE; ARTICLE; BETA THALASSEMIA; BLOOD FLOW VELOCITY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION;

ADULT; ANEMIA, SICKLE CELL; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55549108739     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21272     Document Type: Article

References (22)

1. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-895.
2. Ataga KI, Sood N, De Gent G, et al. Pulmonary hypertension in sickle cell disease. Am J Med 2004;117:665-669.
3. Sachdev V, Machado RF, Shizukuda Y, et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol 2007;49:472-479.
4. Field JJ, Glassberg J, Gilmore A, et al. Longitudinal analysis of pulmonary function in adults with sickle cell disease. Am J Hematol 2008;83:574-576.
5. Gerry JL, Bulkley BH, Hutchins GM. Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia. Am J Cardiol 1978;42:211-216.
6. Tan RT, Kuzo R, Goodman LR, et al. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group. Chest 1998;1135):1250-1256.
7. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-735.
8. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-522.
9. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med 2006;173:1264-1269.
10. Akgul F, Yalcin F, Babayigit C, et al. Right ventricular and pulmonary function in sickle cell disease patients with pulmonary hypertension. Pediatr Cardiol 2006;27:440-446.
11. Anthi A, Machado RF, Jison ML, et al. Hemodynamic and functional assessment of sickle cell disease patients with pulmonary hypertension. Am J Respir Crit Care Med 2007;1272-1279.
12. Bossone E, Paciocco G, Iarussi D, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 2002;121:513-518.
13. Louridas G, Galanis N, Patakas D. Vectorcardiographic and hemodynamic correlation in chronic obstructive pulmonary disease. Chest 1982;82:593-597.
14. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: Analytic review of 131 cases. Chest 2000;118:1133-1141.
15. Kojonazarov BK, Imanov BZ, Amatov TA, et al. Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders. Eur Respir J 2007;29:352-356.
16. Machado RF, Anthi A, Steinberg MH, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006;296:310-318.
17. Voskaridou E, Tsetsos G, Tsoutsias A, et al. Pulmonary hypertension in patients with sickle cell/beta thalassemia: Incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica 2007;92:738-743.
18. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 1991;115:614-620.
19. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000;63:205-211.
20. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: A longitudinal study. Br J Haematol 2006;134:109-115.
21. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
22. Harrigan RA, Jones K. ABC of clinical electrocardiography: Conditions affecting the right side of the heart. Br Med J 2002;324:1201-1204.